Abstract
Introduction: Parkinson’s disease (PD) is a neurodegenerative disorder with social and economic impact. This study estimated its prevalence and comorbidities in Colombia using data from the Ministry of Health’s information system, providing insight into its distribution and burden on the population.
Materials and methods: Data from the RIPS (2018–2022) was analyzed for individuals aged ?50 years, categorized by sex, age, and geographic location. Comorbidities such as sleep apnea, urinary incontinence, dementia, and depression were assessed, calculating prevalence ratios (PR) for each condition.
Results: The crude prevalence was 5.42 per 1,000 inhabitants aged ?50 years (men: 6.65; women: 4.42) and 9.87 per 1,000 aged ?65 years (men: 12.01; women: 8.15). The highest prevalences were in Atlántico, Santander, and Valle del Cauca. PRs were 3.7 for depression, 2.9 for urinary incontinence, 2.4 for sleep apnea, and 14.3 for dementia, highlighting a significant comorbidity burden.
Discussion: PD prevalence in Colombia aligns with international studies, being more frequent in men and older adults. The strong association with comorbidities underscores the need for a comprehensive approach. Limitations include potential underreporting and diagnostic variability, but the use of national data provides a representative perspective.
Conclusions: PD in Colombia shows high prevalence and multiple comorbidities, emphasizing the need for multidisciplinary strategies to improve diagnosis, treatment, and patient quality of life.
References
Bloem BR, Okun MS, Klein C. Parkinson's disease. Lancet. 2021;397(10291):2284-303. https://doi.org/10.1016/S0140-6736(21)00218-X
Sveinbjornsdottir S. The clinical symptoms of Parkinson's disease. J Neurochem. 2016;139(S1):318-24. https://doi.org/10.1111/jnc.13691
Prakash KM, Nadkarni NV, Lye WK., Yong MH., Tan EK. The impact of non?motor symptoms on the quality of life of Parkinson's disease patients: a longitudinal study. Eur J Neurol. 2016;23(5):854-60. https://doi.org/10.1111/ene.12950
Dorsey ER, Sherer T, Okun MS, Bloem BR. The emerging evidence of the Parkinson pandemic. J Park Dis. 2018;8(s1):S3-8. https://doi.org/10.3233/JPD-181474
Hirsch L, Jette N, Frolkis A, Steeves T, Pringsheim T. The incidence of Parkinson's disease: A systematic review and meta-analysis. Neuroepidemiology. 2016;46(4):292-300. https://doi.org/10.1159/000445751
Gonzalez-Alvarez MA, Hernandez-Bonilla D, Plascencia-Alvarez NI, Riojas-Rodriguez H, Rosselli D. Environmental and occupational exposure to metals (manganese, mercury, iron) and Parkinson's disease in low and middle-income countries: a narrative review. Rev Environ Health. 2022;37(1):1-11. https://doi.org/10.1515/reveh-2020-0140
Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, et al. Prevalence of Parkinson's disease across North America. Npj Park Dis. 2018;4(1):21. https://doi.org/10.1038/s41531-018-0058-0
Zhong QQ, Zhu F. Trends in prevalence cases and disability-adjusted life-years of Parkinson's disease: findings from the global burden of disease study 2019. Neuroepidemiology. 2022;56(4):261-70. https://doi.org/10.1159/000524208
Armstrong MJ, Okun MS. Time for a new image of Parkinson disease. JAMA Neurol. 2020;77(11):1345-6. https://doi.org/10.1001/jamaneurol.2020.2412
Wright Willis A, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology. 2010;34(3):143-51. https://doi.org/10.1159/000275491
Moisan F, Kab S, Mohamed F, Canonico M, Le Guern M, Quintin C, et al. Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis. J Neurol Neurosurg Psychiatry. 2016;87(9):952-7. https://doi.org/10.1136/jnnp-2015-312283
Han S, Kim S, Kim H, Shin HW, Na KS, Suh HS. Prevalence and incidence of Parkinson's disease and drug-induced parkinsonism in Korea. BMC Public Health. 2019;19(1):1328. https://doi.org/10.1186/s12889-019-7664-6
Jacobs E, D'Esposito M. Estrogen shapes dopamine-dependent cognitive processes: implications for women's health. J Neurosci. 2011;31(14):5286-93. https://doi.org/10.1523/JNEUROSCI.6394-10.2011
Ishihara L, Brayne C. A systematic review of depression and mental illness preceding Parkinson's disease. Acta Neurol Scand. 2006;113(4):211-20. https://doi.org/10.1111/j.1600-0404.2006.00579.x
Marsh L. Depression and Parkinson's disease: current knowledge. Curr Neurol Neurosci Rep. 2013;13(12):409. https://doi.org/10.1007/s11910-013-0409-5
Aarsland D, Påhlhagen S, Ballard CG, Ehrt U, Svenningsson P. Depression in Parkinson disease-epidemiology, mechanisms and management. Nat Rev Neurol. 2012;8(1):35-47. https://doi.org/10.1038/nrneurol.2011.189
Chen JC, Tsai TY, Li CY, Hwang JH. Obstructive sleep apnea and risk of Parkinson's disease: a population?based cohort study. J Sleep Res. 2015;24(4):432-7. https://doi.org/10.1111/jsr.12289
Lajoie AC, Lafontaine AL, Kimoff RJ, Kaminska M. Obstructive sleep apnea in neurodegenerative disorders: current evidence in support of benefit from sleep apnea treatment. J Clin Med. 2020;9(2):297. https://doi.org/10.3390/jcm9020297
Kaminska M, Lafontaine AL, Kimoff RJ. The interaction between obstructive sleep spnea and Parkinson's disease: possible mechanisms and implications for cognitive function. Park Dis. 2015;2015:1-11. https://doi.org/10.1155/2015/849472
Trotti LM, Bliwise DL. No increased risk of obstructive sleep apnea in Parkinson's disease. Mov Disord. 2010;25(13):2246-9. https://doi.org/10.1002/mds.23231
Oh YS, Kim JS, Lyoo CH, Kim H. Obstructive sleep apnea and striatal dopamine availability in Parkinson's disease. Mov Disord. 2023;38(6):1068-76. https://doi.org/10.1002/mds.29402
Ramos C, Aguillon D, Cordano C, Lopera F. Genetics of dementia: insights from Latin America. Dement Neuropsychol. 2020;14(3):223-36. https://doi.org/10.1590/1980-57642020dn14-030004
Pradilla GA, Vesga BE, León-Sarmiento FE. Estudio neuroepidemiológico nacional (EPINEURO) colombiano. Rev Panam Salud Pública. 2003;14(2):104-11. https://doi.org/10.1590/S1020-49892003000700005
Rosselli D, Pantoja-Ruiz C. SISPRO: La base de datos administrativa del sistema de salud colombiano. Acta Neurol Colomb. 2022;38(4):187-90. https://doi.org/10.22379/24224022426
Jiménez-Pérez CE, Zarco-Montero LA, Castañeda-Cardona C, Otálora Esteban M, Martínez A, Rosselli D. Estado actual de la esclerosis múltiple en Colombia. Acta Neurol Colomb. 2015;31(4):385-90. https://doi.org/10.22379/2422402256
Méndez-Ayala A, Nariño D, Rosselli D. Burden of epilepsy in Colombia. Neuroepidemiology. 2015;44(3):144-8. https://doi.org/10.1159/000381424
Ou Z, Pan J, Tang S, Duan D, Yu D, Nong H, et al. Global trends in the incidence, prevalence, and years lived with disability of Parkinson's disease in 204 countries/territories from 1990 to 2019. Front Public Health. 2021;9:776847. https://doi.org/10.3389/fpubh.2021.776847
Kim DJ, Isidro?Pérez AL, Doering M, Llibre?Rodriguez JJ, Acosta I, Rodriguez Salgado AM, et al. Prevalence and incidence of Parkinson's disease in Latin America: a meta?analysis. Mov Disord. 2024;39(1):105-18. https://doi.org/10.1002/mds.29682
Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C. The epidemiology of Parkinson's disease. Lancet. 2024;403(10423):283-92. https://doi.org/10.1016/S0140-6736(23)01419-8
Benito-León J. Epidemiología de la enfermedad de Parkinson en España y su contextualización mundial. Rev Neurol. 2018;66(4):125-34. https://doi.org/10.33588/rn.6604.2017440
Sun AP, Liu N, Zhang YS, Zhao HY, Liu XL. The relationship between obstructive sleep apnea and Parkinson's disease: a systematic review and meta-analysis. Neurol Sci. 2020;41(5):1153-62. https://doi.org/10.1007/s10072-019-04211-9
Mery VP, Gros P, Lafontaine AL, Robinson A, Benedetti A, Kimoff RJ, et al. Reduced cognitive function in patients with Parkinson disease and obstructive sleep apnea. Neurology. 2017;88(12):1120-8. https://doi.org/10.1212/WNL.0000000000003738
Bottia S, Barrios-Bermúdez H, Rosselli D. Prevalencia de apnea de sueño en Colombia: un análisis de las bases de datos del Ministerio de Salud. Iatreia 2024;37(1):26-34. https://doi.org/10.17533/udea.iatreia.222
Ortiz JL, Rosselli D. Adherence to positive airway pressure therapy in a cohort of Colombian patients with obstructive sleep apnea syndrome. Sleep Sci. 2023;16(02):227-30. https://doi.org/10.1055/s-0043-1770799
Crosta F, Desideri G, Marini C. Obstructive sleep apnea syndrome in Parkinson's disease and other parkinsonisms. Funct Neurol. 2017;32(3):137-41. https://doi.org/10.11138/fneur/2017.32.3.137
Belarbi S, Hecham N, Lesage S, Kediha MI, Smail N, Benhassine T, et al. LRRK2 G2019S mutation in Parkinson's disease: a neuropsychological and neuropsychiatric study in a large Algerian cohort. Parkinsonism Relat Disord. 2010;16(10):676-9. https://doi.org/10.1016/j.parkreldis.2010.09.003
Li FF, Cui YS, Yan R, Cao SS, Feng T. Prevalence of lower urinary tract symptoms, urinary incontinence and retention in Parkinson's disease: a systematic review and meta-analysis. Front Aging Neurosci. 2022;14:977572. https://doi.org/10.3389/fnagi.2022.977572
Yeo L, Singh R, Gundeti M, Barua JM, Masood J. Urinary tract dysfunction in Parkinson's disease: a review. Int Urol Nephrol. 2012;44(2):415-24. https://doi.org/10.1007/s11255-011-9969-y
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.